Sidecar Sync
Sidecar Sync
Amith Nagarajan and Mallory Mejias
How Pfizer thinks about AI, Thomson 1.0, & Who's Behind Ox Alpha? | 150
53 minutes Posted Sep 3, 2026 at 10:00 am.
150 Episodes and Counting
Pfizer's Blueprint: Adoption Isn't Transformation
Federate AI Without Abdicating It
Why AI Fluency Has to Come First
Thomson Reuters Builds Its Own Legal AI Model
Knowledge Agents vs. Custom Models
Why Associations Need Domain-Specific AI
Ox Alpha Unmasked
Closing Takeaway: It's Never Been About the Tech
0:00
53:47
Download MP3
Show notes
Send us Fan Mail A drug company CEO just made the best case yet for why platform choice matters less than most associations think. Marking three years of Sidecar Sync, Amith Nagarajan and Mallory Mejias dig into Pfizer's new playbook for organizing around AI, Thomson Reuters' $40 million bet on building its own legal model instead of renting one, and the six-day mystery of Ox Alpha, an anonymous coding model that became OpenRouter's biggest launch ever. They trace Pfizer CEO Albert Bourla's t...